Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI‐TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast CancerCloud P. Paweletz, Emanuel F. Petricoin, Bruce J. Trock et al.|Disease Markers|2001Cited by 287
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic CancerCraig M. Goodwin, Channing J. Der, Irem Ozkan‐Dagliyan et al.|Cancer Research|2022Cited by 160
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation MappingJulia Wulfkuhle, Emanuel F. Petricoin, Daniela Berg et al.|Clinical Cancer Research|2012Cited by 124
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Justine C. Rutter et al.|Nature Cancer|2022Cited by 42
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker DiscoveryKathy S. Albain, Laura J. Esserman, Christina Yau et al.|Clinical Cancer Research|2023Cited by 20